207,809 Shares in Aspen Aerogels Inc (NYSE:ASPN) Bought by Worth Venture Partners LLC
Worth Venture Partners LLC acquired a new position in shares of Aspen Aerogels Inc (NYSE:ASPN) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 207,809 shares of the construction company’s stock, valued at approximately $1,481,000. Aspen Aerogels comprises approximately 0.8% of Worth Venture Partners LLC’s holdings, making the stock its 20th biggest position. Worth Venture Partners LLC owned 0.86% of Aspen Aerogels at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Deutsche Bank AG increased its holdings in Aspen Aerogels by 30.5% in the 4th quarter. Deutsche Bank AG now owns 66,400 shares of the construction company’s stock worth $141,000 after purchasing an additional 15,500 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in Aspen Aerogels by 2,335.0% in the 2nd quarter. Russell Investments Group Ltd. now owns 48,699 shares of the construction company’s stock worth $347,000 after purchasing an additional 46,699 shares in the last quarter. Wedge Capital Management L L P NC acquired a new position in Aspen Aerogels in the 2nd quarter worth about $735,000. Royce & Associates LP increased its holdings in Aspen Aerogels by 2.4% in the 1st quarter. Royce & Associates LP now owns 870,475 shares of the construction company’s stock worth $2,220,000 after purchasing an additional 20,000 shares in the last quarter. Finally, BlackRock Inc. increased its holdings in Aspen Aerogels by 26.7% in the 2nd quarter. BlackRock Inc. now owns 502,708 shares of the construction company’s stock worth $3,584,000 after purchasing an additional 105,803 shares in the last quarter. Institutional investors and hedge funds own 68.03% of the company’s stock.
ASPN has been the subject of a number of recent research reports. ValuEngine cut Aspen Aerogels from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 4th. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 target price on shares of Aspen Aerogels in a report on Friday, August 2nd.
Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, August 1st. The construction company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.06). Aspen Aerogels had a negative return on equity of 37.52% and a negative net margin of 27.30%. The firm had revenue of $29.53 million during the quarter, compared to analyst estimates of $30.92 million. Sell-side analysts anticipate that Aspen Aerogels Inc will post -0.54 EPS for the current fiscal year.
Aspen Aerogels Profile
Aspen Aerogels, Inc, an aerogel technology company, designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets worldwide. The company provides Pyrogel XT-E that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market with operating temperatures greater than 400 C; Pyrogel XTF to provide strong protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.
Featured Story: What is a portfolio manager?
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.